Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Greystone Research Associates | PRODUCT CODE: 1186912

Cover Image

PUBLISHER: Greystone Research Associates | PRODUCT CODE: 1186912

Oral Solid Dosage Forms - Cardiology Markets

PUBLISHED:
PAGES: 82 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3850
PDF (Site License)
USD 5500
PDF (Enterprise License)
USD 7500

Add to Cart

Introduction

Greystone Research is pleased to announce the publication of a new life science information resource, a comprehensive overview of the markets, products and participants providing the driving force behind the OSDF segment of the drug delivery sector. The report has been designed and developed to provide pharmaceutical company decision makers, drug developers and formulators, drug device designers, and industry strategists with a detailed understanding of the expanding impact of Ora; Solid Dosage Forms on therapies, pharmaceutical strategies and healthcare treatment protocols. Provider organization business managers, healthcare administrators and investors will also benefit from this publication.

Generating Product Improvements in a Mature Market

The generic solid dosage form drug segment is a rapidly evolving and highly unpredictable environment that has been a challenge to decision makers attempting to map strategies for success in this segment. There are 600 distinct APIs for which there is at least one approved generic solid dosage form ANDA. These APIs account for over four thousand approved ANDAs. Including all approved doses, the current universe of generic solid dosage forms consists of thousands of unique tablet and capsule products. These products are marketed and supplied by more than 800 companies. Competition among the various drug and therapeutic classes is uneven, with the top ten segments accounting for a disproportionate level of activity and revenue. Understanding the underlying factors affecting business performance is key to attaining financial targets.

FDA Approved Hypertension APIs

SAMPLE VIEW

OSDF drugs indicated for Hypertension represent more than 90 % of all approved APIs in the Cardiology market segment. This group includes a number of well-known prescription medicines, including:

  • Clonidine
  • Diltiazem
  • Enalapril
  • Felodipine
  • Hydrochlorothiazide
  • Metorprolol
  • Nicardipine
  • Prazosin
  • Trandolapril
  • Verapamil

Other non-hypertensive drugs approved for Cardiology indications include APIs indicated for Angina, Dyslipidemia, Heart Rhythm, Myocardial Infarction, and Peripheral Blood flow.

Drug Strength and Dosing

The visualization on the below illustrates the formulation challenges for OSDF service and technology suppliers. The wide range of dosing categories and the resulting process and QA issues they represent presents opportunities as well facility and equipment issues.

SAMPLE VIEW

Table of Contents

  • Oral Solid Dosage Forms for Cardiology
  • Executive Summary
  • Generic SDFs - Product Considerations
  • Generic Solid Dosage Forms - Cardiology Indications
  • Hypertension
  • Cardiology Therapeutic Classes: All Classes excluding Hypertension
  • Leading Suppliers of OSDF Drugs Indicated for Hypertension
  • Drug Class - Market Presence by Supplier
  • Drug Class - ACE Inhibitors (Abbvie o Graviti Pharms)
  • Drug Class - Ace Inhibitors (Graviti Pharms to Zydus Pharma USA)
  • Drug Class - Adrenoceptor Blocking Agent (Able to Mylan)
  • Drug Class - Adrenoceptor Blocking Agent (Mylan to Zydus Pharms)
  • Drug Class - Angiotensin II Receptor (Ajanta Pharma Ltd to Zydus Pharms)
  • Drug Class - Calcium Channel Blocker (Accord Healthcare to Mutual Pharm)
  • Drug Class - Calcium Channel Blocker (Mylan to Zydus Pharms)
  • Drug Class - Diuretic (Actavis to Monarch Pharms)
  • Drug Class - Diuretic (Actavis to Monarch Pharms)
  • Drug Class - Vasodilator (Actavis to Woodward)
  • Suppliers of OSDFs Indicated for Cardiology
    • Accord Healthcare
    • Actavis
    • Alembic
    • Amneal Pharms
    • ANI Pharms
    • Apotex
    • Aurobindo
    • Dr. Reddy's
    • Glenmark
    • Hikma
    • Lupin
    • Mylan
    • Mylan (Continued)
    • Sandoz
    • Sun Pharma
    • Teva
    • Torrent Pharms
    • Watson Labs
    • Zydus Pharms USA
    • OSDF - Dosage Maps
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!